Journal profile · Radiology, Nuclear Medicine & Medical Imaging
Journal of Vascular and Interventional Radiology
ISSN 1051-0443 · eISSN 1535-7732 · Elsevier Inc. · UNITED STATES · Monthly · Founded 1990
Journal of Vascular and Interventional Radiology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.94; hybrid open access; APC about USD 3,600; median 115 days to acceptance (117 articles, last 24 months); acceptance rate 35% (journal website); 975 articles in 2025; indexed in SCIE and Scopus; the journal's website says it has moved to a new publisher.
The journal's website says it has moved to a new publisher: Video Articles are no longer published by JVIR. Instructional videos may be appropriate for the SIR Now video library, such as in the Early Career Section Channel. Please contact education@sirweb.org for information and submissions. Source ↗Publisher website ·
Scope
Aims, scope and focus
Journal of Vascular and Interventional Radiology is published by Elsevier Inc. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Hepatocellular Carcinoma Treatment and Prognosis, Venous Thromboembolism Diagnosis and Management and Central Venous Catheters and Hemodialysis, together about 25.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Vascular and Interventional Radiology, published continuously since 1990, is a monthly peer-reviewed journal serving the global community and specialty of interventional radiology. The official journal of the Society of Interventional Radiology, JVIR is the authoritative journal of choice for interventional radiologists and other collaborating physicians and scientists in imaging and minimally invasive therapeutic fields who seek current, evidence-based information on every aspect of vascular and interventional radiology. JVIR is committed to the rapid dissemination of important and enduring discoveries in the practice of image-guided interventions. Each issue of JVIR includes clinical, translational, basic science, health policy, socioeconomic, and education-related research on emerging and established domains of the specialty.
From the journal's Aims & Scope
Research area (LetPub): Radiology, Nuclear Medicine & Medical Imaging
Editor-in-chief Brian FunakiPublisher website
Editorial board by country: 2 in mainland China (about 3%); most named United States 55, South Korea 4, Canada 4, Mainland China 2, Singapore 2 (71 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Hepatocellular Carcinoma Treatment and PrognosisMedicine10.9%
- Venous Thromboembolism Diagnosis and ManagementMedicine7.4%
- Central Venous Catheters and HemodialysisHealth Professions6.9%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance6.9%
- Peripheral Artery Disease ManagementMedicine5.7%
- Vascular Procedures and ComplicationsMedicine5.7%
- Liver Disease and TransplantationMedicine4.7%
- Aortic aneurysm repair treatmentsMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.94LetPub ·
- Impact factor (publisher)
- 3.1Publisher website ·
- CiteScore 2026-06
- 3.9LetPub ·
- CiteScore (publisher)
- 3.9Publisher website ·
- SJR 2026-06
- 0.89LetPub ·
- SNIP 2026-06
- 1.25LetPub ·
- h-index
- 120LetPub ·
- h-index
- 178OpenAlex ·
- i10-index
- 5,212OpenAlex ·
- 2-year mean citedness
- 0.77OpenAlex ·
- Self-citation rate
- 16.1%LetPub ·
- Share of gold OA articles
- 10%LetPub ·
Volume
- Articles per year
- 200LetPub ·
Articles by year OpenAlex count · 25,394 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 962 | 207 | 102 |
| 2025 | 975 | 425 | 566 |
| 2024 | 942 | 269 | 1,554 |
| 2023 | 865 | 543 | 2,128 |
| 2022 | 986 | 125 | 2,715 |
| 2021 | 849 | 483 | 3,319 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
115 daysMedian, submission to acceptance · P25–P75 84 days – 164 days
- Acceptance to online
- median 7 days (117 articles)
- Submission to online
- median 127 days
- Sample
- 117 articles with submission and acceptance dates (848 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2.5 monthsLetPub ·
- Average acceptance (community reports)
- 65%LetPub ·
- Acceptance rate (publisher)
- 35%Publisher website ·
- First decision after review
- 55 daysPublisher website ·
- Submission to acceptance
- 128 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,600 / EUR 3,370 / GBP 2,880 / JPY 446,510 | — | — | |
| Publisher website | USD 3,720 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 3,500 words
- Reference style
- AMA
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Graphical abstract
- Optional
- Cover letter
- Optional
Article types accepted7, with length limits
- brief reportBrief Reports may be either clinical or nonclinical, more exploratory or preliminary or lower level of evidence, and narrower in scope than Clinical Study, Labo…main text ≤ 1,800 words · abstract ≤ 150 words · figures and tables ≤ 8
- creative submissionsNonresearch, creative submissions are welcomed from the JVIR community. These may include puzzles, photographs, artwork, medical images, poems, or cartoons.Length not stated
- editorialEditorial, Commentary, and IR History articles are typically invited by the Editor. Book Reviews are invited by the Book Review Editor. Specific instructions ar…main text ≤ 650 words
- evidence-based and narrative reviewsJVIR will review unsolicited Evidence-Based Review articles, which are systematic reviews and meta-analyses. Authors are highly encouraged to register systemati…Length not stated
- hypothesisFULL LENGTH CLINICAL STUDY, LABORATORY INVESTIGATION, or POLICY/ECONOMICS/EDUCATION ARTICLE Clinical Studies (involving human subjects), Laboratory Investigatio…Length not stated
- letter to the editorLetters to the Editor may offer commentary on any material already published in JVIR. Letters that relate to a published article will be published pending respo…main text ≤ 800 words · figures and tables ≤ 6 · references ≤ 4
- original researchFULL LENGTH CLINICAL STUDY, LABORATORY INVESTIGATION, or POLICY/ECONOMICS/EDUCATION ARTICLE Clinical Studies (involving human subjects), Laboratory Investigatio…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Open access, Peer review, Preprints, Trial registration / reporting guidelines
- AI use The Use of Artificial Intelligence
JVIR encourages the use of large language models (LLMs) using artificial intelligence (AI) to improve grammar, spelling, and readability of submissions, and is aligned with the recommendations of ICMJE, WAME, and CSE. Where authors use artificial intelligence (AI) and AI-assisted technologies in the writing process, authors must: 1) Only use these technologies to improve readability and language, …
Source ↗Publisher website ·- Authorship Authorship
Any person listed as a manuscript author should have made substantive intellectual contributions to the study as established by the ICMJE. All authors should meet each of the following conditions with regard to the manuscript: (1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; (2) active role in drafting the article or revising i…
Source ↗Publisher website ·- Conflicts of interest Disclosure instructions
Authors must disclose the use of AI and AI-assisted technologies in the writing process by adding a statement at the end of the manuscript in a new section titled “Declaration of AI and AI-assisted technologies in the writing process.” Statement: During the preparation of this work the author(s) used [PROGRAM and VERSION] in order to [REASON]. After using this tool, the author(s) reviewed and edit…
Source ↗Publisher website ·- Open access Open Access
No APC or page charges except for Open Access options. Model summary
Information on Open Access options may be found on the JVIR information page at Open access options. Aside from Open Access options, JVIR does not levy article processing charges or page charges. Invoices received by authors demanding payment should be considered fraudulent, and should be reported to jvir@sirweb.org and the Elsevier Research Support team. See Seven top tips on stopping APC scams.
Source ↗Publisher website ·- Peer review
Double-blind peer review process. Model summary
JVIR adheres to a double-blind peer review process, and discoverability of the work on a preprint server may jeopardize the confidential review process.
Source ↗Publisher website ·- Preprints PREPRINT SERVERS
Preprint server posting allowed with conditions. Model summary
Posting of a manuscript on a preprint server prior to submission is not necessarily considered to be prior or duplicate publication. However, JVIR editors consider novelty when making manuscript decisions, and if a manuscript receives substantial publicity before or during the peer-review process, suitability for publication may be compromised. JVIR adheres to a double-blind peer review process, a…
Source ↗Publisher website ·- Trial registration / reporting guidelines CONSORT STATEMENT
JVIR formally endorses the CONSORT (Consolidated Standards of Reporting Trials) Statement. The CONSORT Statement contains criteria developed to improve the quality of published reports of randomized clinical trials. The 2010 criteria consist of a 25-item checklist that pertains to the various sections of a report of a clinical trial (Title, Abstract, Introduction, Materials and Methods, Results, a…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1990
- ISSN
- 1051-0443
- Electronic ISSN
- 1535-7732
- Society / sponsor
- Society of Interventional Radiology
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Vascular and Interventional Radiology
What CAS zone is Journal of Vascular and Interventional Radiology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Vascular and Interventional Radiology is in Zone 3 of Medicine, and in Zone 3 of the minor category Peripheral Vascular Disease / Radiology, Nuclear Medicine & Medical Imaging. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Vascular and Interventional Radiology?
The latest impact factor listed by LetPub is 2.94; CiteScore 3.9, h-index 178.
How long does peer review take at Journal of Vascular and Interventional Radiology?
Based on the dates recorded on 117 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 115 days (interquartile range 84–164 days); authors report an average review time of about 2.5 months; the journal's website gives an acceptance rate of 35%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Vascular and Interventional Radiology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 3,500 words; Reference style: AMA; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Graphical abstract: Optional; Cover letter: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Vascular and Interventional Radiology based?
Of the 71 board members whose country the journal's board page names, 2 (about 3%) are in mainland China; the countries named most often are United States (55), South Korea (4) and Canada (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Vascular and Interventional Radiology?
According to LetPub and DOAJ records, Journal of Vascular and Interventional Radiology is indexed in SCIE and Scopus.
Is Journal of Vascular and Interventional Radiology open access, and what is the APC?
Journal of Vascular and Interventional Radiology is a hybrid journal. For open-access publication: APC about USD 3,600.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .